Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Virtus Convertible And Income Fund | NCV-A | Feb 4, 2025 | 21.50 | -0.05 |
Virtus Convertible And Income Fund II | NCZ-A | Feb 4, 2025 | 20.53 | +0.34 |
Virtus Dividend Interest & Premium Strategy Fund | NFJ | Feb 4, 2025 | 12.92 | 0.00 |
Virtus Equity & Convertible Income Fund | NIE | Feb 4, 2025 | 24.77 | +0.77 |
Virtus Global Multisector Income Fund | VGI | Feb 4, 2025 | 7.89 | +1.15 |
Virtus Investment Partners | VRTS | Feb 4, 2025 | 194.56 | -1.00 |
Virtus Stone Harbor Emerging Markets Fund | EDF | Feb 4, 2025 | 5.13 | +0.98 |
Virtus Total Return Fund | ZTR | Feb 4, 2025 | 5.97 | -0.50 |
Visa | V | Feb 4, 2025 | 345.15 | -0.19 |
Vishay Intertechnology | VSH | Feb 4, 2025 | 16.64 | +2.34 |
Vishay Precision Group | VPG | Feb 4, 2025 | 23.00 | +0.09 |
Vision Marine Technologies | VMAR | Feb 4, 2025 | 1.25 | +7.76 |
Visionary Holdings | GV | Feb 4, 2025 | 1.53 | +6.60 |
Vislink Technologies | VISL | Feb 4, 2025 | 2.51 | +23.65 |
Vista Gold | VGZ | Feb 4, 2025 | 0.64 | +1.56 |
Vista Oil & Gas A ADR | VIST | Feb 4, 2025 | 53.26 | +0.87 |
Vistagen Therapeutics | VTGN | Feb 4, 2025 | 2.86 | -1.72 |
Visteon | VC | Feb 4, 2025 | 82.66 | +1.75 |
Vistra | VST | Feb 4, 2025 | 168.33 | -0.12 |
Vita Coco | COCO | Feb 4, 2025 | 37.40 | +1.03 |
Vital Energy | VTLE | Feb 4, 2025 | 32.63 | +6.39 |
Vital Farms | VITL | Feb 4, 2025 | 38.01 | -4.69 |
Vitesse Energy | VTS | Feb 4, 2025 | 26.53 | +2.24 |
Vivakor | VIVK | Feb 4, 2025 | 1.00 | +2.56 |
Vivani Medical | VANI | Feb 4, 2025 | 1.17 | 0.00 |
Vivid Seats A | SEAT | Feb 4, 2025 | 4.53 | +4.38 |
VivoPower International | VVPR | Feb 4, 2025 | 1.06 | 0.00 |
Vivos Therapeutics | VVOS | Feb 4, 2025 | 3.81 | -2.31 |
Vizsla Silver | VZLA | Feb 4, 2025 | 2.20 | +6.80 |
VNET ADR | VNET | Feb 4, 2025 | 7.54 | +4.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.